Growth is fueled by rising procedural volumes, particularly in outpatient settings such as urology-focused Ambulatory ...
"Many supplements have real biologic effects, and when you layer them on top of blood thinners, you can tip into either bleeding or clotting without realizing it," warns Dr. Joseph Allencherril, MD, a ...
The Authority ruled that medicines, consumables, and implants supplied to inpatients are inseparably linked to treatment and form a composite supply of healthcare services. As the principal supply is ...
Dexcom's 2026 revenue estimates lagged analysts' expectations, according to data compiled by the London Stock Exchange Group (LSEG).
The mother of a 3-year-old boy who died of fentanyl poisoning must remain in the Napa County jail ahead of a murder trial, a judge ruled — and the child’s father, also charged ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 first quarter, which ended December 31, 2025.
Revenue of $5.3 billion increased 1.6% as reported, 0.4% FXN New BD revenue increased 2.5% FXN GAAP and adjusted diluted EPS of $1.34 and $2.91, respectively Combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results